eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2015-10-25 8 October Spl Edition 685 690 10.13005/bpj/768 4317 article Sudhakar Mishra 1 T. R. Parthsarthy 2 Bagavad Gita 3 Chithra R. Chandran 2 Kanhaiya Lal 1 Department of Oral and Maxillofacial Surgery, Tagore Dental College and Hospital, Rathinamangalam, Melakottaiyur Post, Chennai – 600127, India Department of Periodontics, Tagore Dental College and Hospital, Rathinamangalam, Melakottaiyur Post, Chennai - 600127, India. Department of Periodontics, Sree Balaji Dental College AND Hospital, Bharath University, Chennai - 600100, India. Recognition and diagnosis of the general oral manifestations and specific periodontal manifestations of HIV infection will continue to be a major responsibility of the dental practitioner. By combining local and systemic therapy aimed at both preventing and treating oral lesions and periodontal diseases, combined with new systemic antiviral and vaccine therapies, dental and medical practitioners may together help reduce both the dental morbidity and the overall patient morbidity in the HIV infected patient. With the advent of newer pharmacological approaches to the treatment of human immunodeficiency virus (HIV) infection, the incidence and progression of both atypical and conventional periodontal diseases are changing. While the accepted approaches to treating the spectrum of periodontal diseases in HIV patients remain essentially unchanged over the past 15 years, the impact of newer systemic therapies on patient immunocompetence may influence treatment decisions. https://biomedpharmajournal.org/vol8octoberspledition/periodontal-management-of-hiv-infected-patients-an-overview/ HIV periodontitis immunocompetence systemic antiviral and vaccine therapies highlyactiveantiretroviraltherapy